Abstract
We used peripheral blood mononuclear cells (PBMCs) from a healthy 14-day-old boy donor to reprogram a pluripotent stem cells (iPSCs) line. The iPSCs line SDQLCHi049-A had a normal karyotype, pluripotent markers, and three-line differentiation potential. This cell line can be used as a control model for study on pathological mechanisms of diseases and drug development, particularly for study of childhood diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
